If you liked this article you might like

Sarepta Updates Eteplirsen Study Results, FDA Filing Still on for Mid Year
Jim Cramer's 'Mad Money' Recap: Knowing Where to Look for Bargains
Prosensa Holding (RNA) Upgraded From Sell to Hold
The Nominees for Best Biotechnology Co. CEO of 2014 Are...